Skip to content


November 8, 2018

The Premier Life Science Conference in Texas

2018 Speakers

Name Title Company
Adil Adi Executive Chairman, WorldLink; Founder and Prinicpal, Adi Foundation Adi Family Office
Varsin Archer Project Manager SwRI
David Arthur CEO Salarius Pharmaceuticals
Guillermo Borda Fund Manager HX Venture Fund
Meg Boulware Partner Boulware & Valoir
Gretchen Miller Bowker, MS, RAC, FRAPS Chief Executive Officer, Pearl Pathways Pearl Pathways
Greg Brown, M.D. Special Advisor, Back Bay HealthCare Capital Back Bay HealthCare Capital
Scott C. Brun, M.D. Vice President, Scientific Affairs; Head, AbbVie Ventures, AbbVie HQ AbbVie Ventures
Carlyn Burton Partner and Patent Attourney, OshaLiang LLP OshaLiang LLP
Bruce Butler, Ph.D. Vice President, Research and Technology; Director, Office of Technology Management UT Health Science Center Houston
Stephanie Campbell Managing Director, Houston Angel Network Houston Angel Network
Danielle Supkis Cheek,


Director PKF Texas
Paul Cherakuri, Ph.D. Executive Director, IBB, Rice University Rice University
Casey Cunningham, M.D. Chief Scientific Officer Santé Ventures
Susan Davenport Senior Vice President, Economic Development Greater Houston Partnership
Andrew Dennis, Ph.D. Managing Director, Technology Commercialization, MD Anderson Cancer Center MD Anderson Cancer Center
Michael Dilling Director, Baylor Licensing Group Baylor College of Medicine
Erik Halvorsen, Ph.D. Director TMC Innovation Institute
Bill Kadel
[ presentation ]
Vice President Solebury Capital
Oliver Keown, MBChB Healthcare Investor GE Ventures
Shafin Khan, J.D. Licensing Associate, Office of Technology Transfer and Intellectual Property Development Tulane University
Jeffrey Larson, Ph.D., DABT Vice President, Nonclinical Development Salarius Pharmaceuticals
Samantha Lewis Director GOOSE Society of Texas
Michael Liang, Ph.D. Partner Baird Venture Partners
Mike Liccardo VP of Corporate Development and CFO ShareVault
John Lockwood, RAC, CQA, CSQE Director, Quality Assurance and Regulatory Affairs Pearl Pathways
Tom Luby, Ph.D. Head JLABS @ TMC
Gina Luna HX Board Chair & Interim CEO Houston Exponential (HX)
Tim Marx Venture Partner Baird Capital
Joe McDonough Manager, Synthesis and Drug Delivery SwRI
David B. McWilliams Chairman BioHouston
David Novotny Chief Strategy Officer Proxima Clinical Research
Mike Perry, Ph.D. Managing Director BioScience Managers
Roberto Roitz Innovation Director, Humana Humana Health Ventures
Gabriela Rowe CEO Station Houston
Jacob Setterbo, Ph.D. Director of Grants HIRETech
Larry Shaffer Senior Vice President Marketing & Business Development Insperity
Gregory Stein Licensing Associate, Office of Technology Transfer and Intellectual Property Development Tulane University
Tong Sun Vice President of Central Operations Houston Methodist Research Institute
Jaye Thompson, Ph.D. Co-founder and COO Proxima Clinical Research
Brian Toglia President and CEO Galiot Insurance
Rob Tucci Managing Director Texas Halo Fund
Atul Varadachary, Ph.D. Managing Partner, Fannin Innovation Studio Fannin Innovation Studio
Jeffrey Wade, J.D. Executive Vice President, Corporate and Administrative Affairs and CFO Lexicon Pharmaceuticals
Nicholas Wharton SVP, Business Development & Strategic Partnerships Medical Metrics
Angela Wilkins, Ph.D. Founder and Managing Director Mercury Data Science


Comments from Attendees at the 2017 Texas Life Science Forum

"TXLSF is the premier event for connecting companies, ideas, investors, and scientists!"

"This is a cannot miss event. All of the major players in Texas are there and are accessible on a personal basis."

"Plenary and company presenter sessions excellent - logistics good, timing excellent. Educational sessions I attended were very useful and interesting - and on appropriate topics."